Schedule 13D ownership disclosure
Soleno Therapeutics Inc
Security class unavailable · CUSIP: 834203309
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 4.9900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000908834-23-000049
- Form type
- SC 13D
- Filer
- SCHULER JACK W
- CIK
- CIK 1021412
- Filed
- May 26, 2023
- Reporting period
- —
- Description
- Schedule 13D beneficial ownership